INTRODUCTION
To ensure accurate segregation, the major cell cycle control mechanism in mitosis, the mitotic checkpoint (or the spindle assembly checkpoint), delays anaphase onset until all chromosomes have properly attached to spindle microtubules. The checkpoint-derived inhibitor(s) blocks premature destruction of key mitotic components. This is achieved by selectively inhibiting Cdc20-stimulated recognition of the mitotic regulators cyclin B and securin by a multisubunit E3 ubiquitin ligase, the anaphase-promoting complex/cyclosome (APC/C). Checkpoint silencing and subsequent deactivation of the checkpoint arrest releases APC/C Cdc20 for ubiquitination of cyclin B and securin, with anaphase triggered by their degradation by the proteosome (reviewed in Peters, 2006) .
By correlating the timing of anaphase onset with spindle microtubule capture by the last unattached chromosome (Rieder et al., 1994) , laser ablation of the last unattached kinetochore (Rieder et al., 1995) , and micromanipulation (Li and Nicklas, 1995) , researchers first implicated unattached kinetochores as essential for generation of the ''wait anaphase'' inhibitor. Key proteins essential for mitotic checkpoint signaling include Mad1, Mad2, Bub3, CENP-E, Zw10, Rod, and the kinases Mps1, Bub1, and BubR1 (reviewed by Musacchio and Salmon, 2007) , each of which is at least transiently localized to unattached kinetochores during early mitosis. Fluorescence recovery after photobleaching (FRAP) demonstrated that Mad2, BubR1, and Cdc20 cycle on and off kinetochores rapidly (Howell et al., 2000 (Howell et al., , 2004 Kallio et al., 2002; Shah et al., 2004) . Additionally, several APC/C subunits are at least partially localized onto unattached kinetochores (Acquaviva et al., 2004; Jorgensen et al., 1998) , supporting the possibility that one or more of its components are sensitized for checkpoint inhibition there.
Inhibition of Cdc20 activation of APC/C has previously been attributed to Mad2 (Fang et al., 1998a) or BubR1 (Tang et al., 2001) , both of which can bind Cdc20 directly and in so doing have been shown to reduce APC/C Cdc20 ubiquitination activity accordingly. A complex, named the mitotic checkpoint complex (MCC) and proposed to comprise Mad2, BubR1, Bub3 and Cdc20, has been reported to inhibit APC/C much more potently than Mad2 alone (Sudakin et al., 2001) . However, the existence of MCC-like complexes has been noted outside of mitosis (Sudakin et al., 2001) or in the absence of a functional kinetochore (Fraschini et al., 2001) . The simplest view is that an interphase mechanism independent of kinetochores generates a premade inhibitor(s) of Cdc20 that requires Mad2 and BubR1 and whose half-life sets a minimum time before anaphase onset (Meraldi et al., 2004) .
A ''template'' model for kinetochore-dependent activation of Mad2 (De Antoni et al., 2005) , a modified version of the ''twostate '' model (Yu, 2006) , has emerged from use of cultured cells, purified components in the absence of chromosomes, and the discovery that Mad2 can undergo a large conformational change in which its carboxy-terminal ''seatbelt'' domain encloses either Mad1 or Cdc20, thereby converting the initial Mad2 from an ''open'' (or ''N1'') to a ''closed'' (or ''N2'') conformation (Luo et al., 2000 (Luo et al., , 2002 (Luo et al., , 2004 Sironi et al., 2002 Sironi et al., , 2001 . The closed conformation has been proposed to sequester Cdc20 from binding to and activating APC/C for recognition of cyclin B through direct capture of Cdc20 by Mad2 (Luo et al., 2004) . The carboxy-terminal domain of Mad1 has been shown to directly bind a molecule of Mad2 in the closed conformation (Luo et al., 2002 (Luo et al., , 2004 Sironi et al., 2002 Sironi et al., , 2001 . FRAP has revealed that Mad1 at kinetochores, presumably bound to Mad2, is nonexchangeable, while two equally sized pools of kinetochore-associated Mad2 either cycle on and off rapidly (within a few seconds) or are more stably bound (Shah et al., 2004) . Mad2 mutants impaired in dimerization were subsequently shown to be unable to support either mitotic checkpoint signaling in vivo (De Antoni et al., 2005; Mapelli et al., 2006; Nezi et al., 2006) or capture of Cdc20 (using a 27 amino acid peptide to mimic Cdc20) by Mad2 in a complex with a 233 amino acid Mad2-binding fragment of Mad1 (De Antoni et al., 2005; Nezi et al., 2006) .
Use of in vitro FRAP demonstrated recruitment of a rapidly exchangeable Mad2 by a second stably associated Mad2 bound in the closed conformation to full-length or a fragment of Mad1 (Vink et al., 2006) . There is, however, no evidence for facilitating conversion of soluble Mad2 to Mad2-Cdc20, and the rate of Mad2 dissociation from the immobilized Mad1/Mad2 is independent of the Cdc20 peptide (Vink et al., 2006) . Moreover, the majority of the cellular Mad2, which is present at approximately equimolar concentrations to Cdc20 during mitosis (Tang et al., 2001) , remains in the open conformation that is less capable of interacting with Cdc20 (Luo et al., 2004) . Thus, neither the identity(ies) of the checkpoint-derived wait anaphase inhibitor nor how unattached kinetochores participate in its production is established. We have now used purified components to determine that unattached kinetochores catalyze production of a diffusible wait anaphase inhibitor by using a Mad2 template to prime Cdc20 for BubR1 binding.
RESULTS

Mad2 Recruitment to Unattached Kinetochores on Purified Chromosomes
To reconstruct kinetochore-mediated mitotic checkpoint signaling with all purified components, successive sucrose gradients were used to isolate chromosomes with unattached kinetochores from colcemid-arrested, mitotic HeLa cells stably expressing histone H2B-YFP ( Figure 1A ). Morphologically intact, condensed chromosomes were obtained, as observed by YFP fluorescence of unfixed chromosomes ( Figure 1B ). Tubulin was reduced to less than 1/40 th of its concentration in the initial cell extracts ( Figure 1D ), while histones (including H2B-YFP and the mitotic-specific phosphorylated histone H3) and kinetochore-associated kinesin-like motor protein CENP-E were nearly quantitatively retained ( Figure 1C ). Components previously reported by FRAP to be stably bound to unattached kinetochores, including Bub1 and Mad1 (Howell et al., 2004; Shah et al., 2004) , were also retained, as was Mps1 and a proportion of Aurora B ( Figure 1C ).
Using anti-centromere antisera (ACA) and immunofluorescent staining of fixed, DAPI-stained chromosomes, Bub1, Mad1, and CENP-E were demonstrated to remain kinetochore bound ( Figure 1E ). Components for which FRAP had revealed rapid cycling, including BubR1, Bub3, and Cdc20, were undetectable by immunoblotting of the purified chromosome fractions (Figure 1C) (their levels in purified chromosomes were all %1.1% of the cytosolic levels; see Figures S1A and S1C available online). Although a portion of Mad2 is known to be stably bound at an unattached kinetochore for at least 2 min in vivo (Shah et al., 2004) , Mad2 nearly completely dissociated from most kinetochores during the 7 hr required for chromosome isolation ( Figure 1C) , with faint levels detectable by immunofluorescence remaining only on a minority (20.1%) of isolated chromosomes ( Figure 1E ).
Bacterially produced Mad2 was isolated under conditions promoting primarily the retention of the open monomeric conformation, the conformation thought to be representative of cytosolic Mad2 (Luo et al., 2004; Mapelli and Musacchio, 2007) . After covalent ligation of rhodamine ( Figure 1F ; see Figure S3A for activity assessment) and addition to purified chromosomes, rhodamine-Mad2 bound to unattached kinetochores of the majority of chromosomes ( Figure 1G ; see also Figure S3C for quantification). At least a portion of this Mad2 binding was mediated through kinetochore-associated Mad1, as demonstrated by partial blocking even by brief preincubation of the chromosomes with an antibody against Mad1 ( Figure 1H ).
Generation by Unattached Kinetochores of an APC/C-Cdc20 Inhibitor
To determine how unattached kinetochores produce a mitotic checkpoint signal, we established an in vitro assay for Cdc20stimulated ubiquitination by APC/C. Human homologs of Mad2 and BubR1, as well as Bub3, Cdc20, and the APC/C G1-specific activator Cdh1 (Fang et al., 1998b) , were purified after production in bacteria or in insect cells using baculovirus (Figures 2A and 2B) . APC/C was immunoprecipitated ( Figure 2C ) from Xenopus interphase or mitotic extracts with an antibody against the Cdc27 subunit. Immunoblotting of mitotic APC/C revealed slowed mobility of Cdc27 both in the initial mitotic extract and after isolation ( Figure 2G ), a shift known to reflect mitotic phosphorylation (Kraft et al., 2003) . Addition of Cdc20 to either APC/C equivalently activated the ubiquitination of cyclin B 1-102 (Figures 2E and 2H) , which could be quantified either by the presence of slower mobility cyclin B species (Figure 2E , top; Figure 2H ) or the intensity of the remaining unubiquitinated cyclin B (Figure 2E , bottom).
Basal inhibition of APC/C Cdc20 ubiquitination activity by our purified checkpoint proteins was initially assayed in the presence of equal molar amounts of Mad2, BubR1, or Bub3 to approximate the relative in vivo stoichiometries (see Figure S1 ). Under these conditions addition of Mad2, Bub3, or BubR1 alone did not significantly inhibit ubiquitination of cyclin B, while the combination of Mad2 and BubR1 did, independent of Bub3 ( Figure 2E , compare lanes 3-6 with lanes 7 and 8). Inhibition was selective for Cdc20mediated activation of APC/C, as similar addition to APC/C Cdh1 left ubiquitination activity undiminished ( Figure S2A ). BubR1 was a significantly better inhibitor of Cdc20 activation of APC/ C: a >10-fold molar excess of Mad2 over Cdc20 was necessary to achieve >50% inhibition, whereas 10 times less of BubR1 with or without Bub3 was required for equivalent APC/C Cdc20 inhibition ( Figures 2J and 2K ; Figure S2B ). Nevertheless, there was synergism between Bub3/BubR1 and Mad2. Inhibition by the combination of Bub3/BubR1 and Mad2 was greater than the additive effect of each alone. Suppression of cyclin B ubiquitination by BubR1 was enhanced by Mad2 such that a quarter of the amount of BubR1 was required for equivalent inhibition of Cdc20 in the presence of Mad2 ( Figure S2B , lane 8 versus 13), even though the same amount of Mad2 alone produced no inhibition ( Figure S2B , lane 6 versus 13), results similar to an earlier report in which Mad2 and Bub3/BubR1 cooperate to inhibit Cdc20 even in the absence of unattached kinetochores (Fang, 2002) .
Addition to APC/C Cdc20 of increasing levels of Mad2 alone produced dose-dependent inhibition of cyclin B ubiquitination ( Figure 2J , lanes 3-6), but even a 20-fold excess of Mad2 over Cdc20 produced only 50% inhibition. In the absence of chromosomes, BubR1 yielded comparable inhibition of APC/C Cdc20 at 10-to 20-fold lower levels than required for Mad2. Although purified chromosomes alone minimally inhibited APC/C Cdc20 , addition of them to a concentration approximating ten unattached kinetochores per cell volume amplified the inhibition produced at all concentrations tested of added Mad2 (Figure 2J , lanes 8-11), but not BubR1 ( Figure 2K ). Equivalent inhibition of mitotic and interphase APC/C Cdc20 by a combination of Mad2, Bub3, and BubR1 was seen at all concentrations, both in the presence and absence of chromosomes ( Figure 2H ). For example, although equimolar additions of Mad2, Bub3, and BubR1 produced minimal inhibition of Cdc20-dependent activation of APC/C, unattached kinetochores produced equivalent inhibition at 10-fold lower levels of added Mad2 and BubR1/ Bub3 ( 
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Chromosomes ----- selective for Cdc20, as APC/C Cdh1 ubiquitination of cyclin B was unaffected even at maximal doses of Bub3/BubR1, Mad2, and chromosomes ( Figure 2I ). Chromosome amplification of APC/C Cdc20 inhibition was greatest at the lowest concentrations of added Mad2 and BubR1/Bub3, with maximal inhibition 35fold higher than that seen in the absence of chromosomes ( Figure 2L , 0.13 concentration).
Mad2 Dimerization Is Required for Kinetochore Amplification of Cdc20 Inhibition
To determine if recruitment of Mad2 to unattached kinetochores via Mad1 (Chen et al., 1998) and Mad2 binding directly to Cdc20 were required for chromosome amplification of APC/C Cdc20 inhibition, APC/C activity assays were performed with wild-type Mad2 or a Mad2 mutant that can bind to kinetochore-associated Mad1 or Cdc20 but is incompetent for dimerization onto Mad1/ Mad2 complexes ( Figure 3A ). For this, we chose the Mad2 RQ mutant (carrying the two amino acid substitution R133E, Q134A), previously demonstrated as incapable of supporting full mitotic checkpoint function in vivo (De Antoni et al., 2005) ( Figures 3B and 3C ). Incubation of rhodamine-labeled Mad2 RQ ( Figure S3B ) with purified chromosomes yielded Mad2 localization to kinetochores with equal frequency as wild-type Mad2 ( Figure S3C ), yet with approximately half the intensity (Figure S3D) . Thus, Mad2 RQ bound directly to Mad1 at kinetochores mostly depleted of endogenous Mad2 ( Figure 1C ), yet was unable to recruit a second Mad2 molecule to form Mad2 dimers. In the absence of chromosomes, Mad2 RQ inhibited Cdc20stimulated APC/C ubiquitination almost as well as wild-type Mad2 did ( Figure 3D ; Figure S4A ). This Cdc20 inhibition required direct binding of Mad2 to Cdc20: Mad2 mutants (Mad2 DC or Mad2 RQ-DC ; Figures 3B and 3C ) missing the carboxy-terminal 10 amino acids that are required for Cdc20 binding (Luo et al., 2000) did not inhibit APC/C Cdc20 at any concentration ( Figure 3D ; Figure S4A ).
In contrast to wild-type Mad2, the dimerization-deficient Mad2 RQ was incapable of supporting chromosomal amplification of APC/C inhibition at any added concentration ( Figure 3E ; Figure S4B ). Moreover, when tested for synergy with Bub3/ BubR1 and chromosomes in inhibiting APC/C Cdc20 , Mad2 RQ was much less efficient than wild-type Mad2 ( Figure 3F ; Figure S4C ), thus supporting action by kinetochores on Mad2 for amplifying generation of a Cdc20 inhibitor.
Kinetochore-Bound Mad1 Is Required for Chromosome-Mediated Amplification of a Cdc20 Inhibitor
To further test the Mad1 role in the chromosome-dependent amplification of an APC/C Cdc20 inhibitor, a Mad1 antibody raised against the region that spans the Mad2-binding domain was added to isolated chromosomes in an effort to inhibit its function at kinetochores ( Figure 3G ). This substantially reduced Mad2 recruitment to kinetochores ( Figure 1H ), as anticipated. In the absence of chromosomes or Mad2, Mad1 antibody had no effect on APC/C Cdc20 ubiquitination ( Figure 3H ). In the presence of a 5-fold excess of Mad2 (the concentration chosen for the greatest enhancement of inhibition upon addition of chromosomes), chromosomes amplified APC/C Cdc20 inhibition 7-fold, but this amplification was almost eliminated by Mad1 antibody addition ( Figure 3H ; Figure S4D ). Thus, Mad1 at kinetochores is required both for kinetochore recruitment of Mad2 and chromosomemediated enhancement of inhibition of APC/C Cdc20 .
Kinetochore-Enhanced Inhibition of Cdc20 Bound to APC/C Models of APC/C inhibition in mitosis initially focused upon sequestration of Cdc20 (Fang et al., 1998a; Tang et al., 2001) as the mode of preventing Cdc20 activation of APC/C. An alternative is inhibition by a checkpoint-derived inhibitor binding directly to Cdc20 already bound to APC/C. To distinguish between these models, inhibition of APC/C Cdc20 activity was assessed either by preincubation of chromosomes, Bub3/BubR1, Mad2, and Cdc20 followed by addition of APC/C ( Figure 4A ) or by addition of chromosomes, Bub3/BubR1, and Mad2 to Cdc20 prebound to APC/C ( Figure 4B ). At all concentrations of checkpoint components, inhibition of APC/C Cdc20 -mediated ubiquitination of cyclin B 1-102 was comparable following coincubation with Cdc20 or after preactivation by binding of Cdc20 to APC/C ( Figure 4C ; Figure S5 ). Thus, APC/C Cdc20 can be directly inhibited by a kinetochore-derived inhibitor(s), and a model of simple sequestration of Cdc20 cannot be the sole means by which APC/C is held inactive for cyclin B ubiquitination.
A Soluble Kinetochore-Derived Cdc20-BubR1-Bub3 Inhibitor To test whether a soluble kinetochore-derived inhibitor of Cdc20 can be produced, chromosomes with unattached kinetochores were incubated with BubR1, Bub3, Mad2, and Cdc20, but then removed prior to the addition of APC/C ( Figure 5A ; Figure S6A ). In the absence of chromosomes, incubation of Cdc20 and a low level of BubR1, Bub3, Mad2, and Cdc20, followed by subsequent addition of APC/C, produced almost fully active APC/C Cdc20 . Parallel incubation of the same amounts of BubR1, Bub3, Mad2, and Cdc20 but now in the presence of chromosomes amplified APC/C inhibition greater than 3-fold, independently of whether chromosomes were removed prior to of lower mobility ubiquitin-conjugated cyclin B species) assessed after addition of increasing amounts of BubR1, Bub3, and Mad2 to Cdc20, either in the presence or absence of chromosomes. (I) BubR1, Bub3, Mad2, and chromosomes were incubated with either (red bar) Cdc20 or (blue bar) Cdh1 activators, prior to APC/C activity determination. Incubations with Cdc20 rendered the APC/C almost fully inactive, while Cdh1 incubations had no effect on the activity of APC/C. (J-L) Chromosomes (blue squares) at a final concentration equaling ten unattached kinetochores per cell volume or just buffer (red triangles) were added to increasing concentrations of (J) Mad2, (K) Bub3/BubR1, or (L) both, incubated for 1 hr prior to addition of APC/C, and then assayed for APC/C ubiquitination of myc-cyclin B 1-102 . APC/C activity was quantified by the intensity of remaining unubiquitinated cyclin B. Mad2 inhibition of APC/C in the presence of chromosomes increased, while BubR1 inhibition remained unchanged. Chromosomes further amplified APC/C inhibition when added to the combination of Mad2, BubR1, and Bub3 at physiological concentrations. Error bars represent standard error of the mean calculated from at least three independent assays.
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Catalytic Kinetochores Generate a Cdc20 Inhibitor APC/C addition. Thus, a soluble inhibitor(s) amplified by unattached kinetochores is produced independently of APC/C.
Unattached Kinetochores Act on Mad2 to Amplify a Cdc20 Inhibitor
To test if unattached kinetochores act directly on Mad2, chromosomes and Cdc20 were incubated with Mad2, the chromosomes were then removed, BubR1/Bub3 was added, and finally APC/C was added and assayed for ubiquitination of cyclin B. Comparable to the stimulated inhibition of Cdc20 found when all components were incubated together with chromosomes ( Figures 2L and 5A) , a 4-fold stimulation of inhibitory activity was generated when only Mad2 and Cdc20 were coincubated with chromosomes ( Figure 5B; Figure S6B ). Thus, amplification of a Cdc20 inhibitor with purified components does not require unattached kinetochores acting directly on either APC/C or BubR1/Bub3, but rather can be produced by direct interaction with Mad2 and/or Cdc20.
Catalytic Production by Unattached Kinetochores of a Mad2 Cdc20 Inhibitor
A central unresolved question is whether unattached kinetochores act catalytically in the production of a Cdc20 inhibitor. A central requirement of a catalytic model would be for unattached kinetochores to accelerate the rate of production of a Cdc20 inhibitor, while an extended incubation without kinetochores could ultimately yield comparable inhibition mediated by an uncatalyzed, spontaneous process. To test the catalytic model, Mad2 and Cdc20 were added to a level sufficient to yield 40% inhibition after extended incubation without addition of chromosomes. In the absence of chromosomes, a linear increase in inhibition of Cdc20 was produced over the first 120 min, ultimately plateauing at about 40% inhibition by 4 hr (Figure 5C ; Figure S6C ). As required for chromosome-dependent catalysis, the presence of a concentration of chromosomes corresponding to ten unattached kinetochores per cell accelerated the initial rate of inhibitor production 8-fold (initial slopes of 2.5 versus 0.3% inhibition/min in the presence and absence of chromosomes, (E) Mad2 RQ inhibition of Cdc20 activation of APC/C assessed after incubating increasing quantities with Cdc20 either in the (blue squares) presence or (red triangles) absence of chromosomes before assaying cyclin B ubiquitination. (F) Testing chromosome amplification of a Cdc20 inhibitor after increasing concentrations of (green circles) Mad2 RQ or (blue squares) Mad2 wt , along with BubR1, Bub3, and Cdc20, either in the presence or (red triangles) absence of chromosomes.
(G and H) (G) Purified chromosomes were incubated with Mad1 antibody for 1 hr prior to addition of a 5-fold excess of Mad2 to Cdc20, and finally addition to APC/C ubiquitination assays, and (H) inhibition of APC/C Cdc20 was measured. Error bars represent standard error of the mean calculated from at least three independent assays.
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Catalytic Kinetochores Generate a Cdc20 Inhibitor respectively) ( Figure 5C) , with the final level of inhibition similar to that produced spontaneously.
Kinetochores Facilitate Bub3/BubR1 Binding to APC/C Cdc20
To probe whether the unattached kinetochores on purified chromosomes altered the composition of proteins bound to APC/C, a peptide-derived antibody to Cdc27 (Herzog and Peters, 2005 ) was used to affinity purify APC/C. After preincubation of Cdc20, BubR1, Bub3, Mad2, and chromosomes, bead-bound APC/C was added, the beads were recovered, and APC/C and proteins bound to it were released by addition of a competing Cdc27 peptide. Immunoblotting revealed that similar amounts of Cdc20 coimmunoprecipitated with APC/C regardless of the concentrations of coincubated checkpoint components ( Figure 6A) . While a proportion of Mad2 has previously been reported to be associated with APC/C (Fang et al., 1998a; Kallio et al., 1998) , Mad2 binding to APC/C was not Cdc20 dependent (lane 11). A small, variable proportion of Mad2 and Mad2 RQ bound to APC/C independently of chromosomes, revealing a direct affinity of Mad2 for APC/C that was modestly increased by the presence of chromosomes (Figures 6A, 6D, and 6E ). Neither BubR1 nor Bub3 bound APC/C in the absence of Mad2. Bub3/BubR1 did, however, bind to APC/C in a Mad2-dependent manner that at all concentrations tested was further enhanced by up to 4-fold by chromosomes (Figure 6A , compare lane 4 with lanes 9 and 10; Figures 6B and 6C) . However, the number of BubR1 molecules bound to APC/C Cdc20 after incubation with chromosomes was always greater than the number of bound Mad2 molecules, as seen by a stoichiometry of greater than 1:1 ( Figure 6E ), inconsistent with MCC-like complexes that would contain equal stoichiometries of Mad2 and BubR1/Bub3. This chromosomeenhanced BubR1/Bub3 binding was not supported by the dimerization-incompetent Mad2 RQ ( Figure 6A , lane 13 versus 15; Figures 6B, 6C, and 6E ). Sucrose gradient sedimentation of the complexes released from the initial antibody-coated beads confirmed a 2-to 3-fold, chromosome-dependent increase in BubR1/Bub3 bound to APC/C ( Figure 6F ). Thus, Bub3/BubR1 binding to APC/C is facilitated by dimerization-competent Mad2 and unattached kinetochores through a mechanism that does not affect Cdc20 interaction with APC/C.
A Soluble Kinetochore-Derived Cdc20-BubR1-Bub3 Inhibitor
To determine the composition(s) of complexes produced spontaneously or by action of unattached kinetochores in the absence of APC/C, equal stoichiometries of various combinations of BubR1, Bub3, Mad2, and Cdc20 were incubated with or without purified chromosomes, the chromosomes were removed, and the inhibitor-containing supernatant (as in Figure 4A ) was subjected to size-exclusion chromatography. As expected, Bub3 shifted into a larger complex, coeluting with BubR1 under all conditions. Most Cdc20 shifted into a substantially higher molecular weight complex both in the presence ( Figure 7E ) and absence ( Figure 7D ) of chromosomes, eluting together with BubR1 and Bub3 (centered on fractions 12 and 13). Except for a small proportion of Mad2 bound to Cdc20 when incubated alone with it ( Figure 7C) , surprisingly little Mad2 chromatographed with Cdc20 under any condition, eluting instead at a position corresponding to a Mad2 monomeric form, regardless of the presence of chromosomes and/or BubR1/Bub3. Very little Mad2 was found in an MCC-like tetrameric complex with BubR1, Bub3, and Cdc20 in the absence of chromosomes, even when using conditions that produced up to 80% inhibition of Cdc20's ability to activate APC/C ( Figure 2L ). Incubation with chromosomes eliminated even this small amount of MCC-like complex (Figures 7D and 7E) . (A) Checkpoint components including Cdc20 and chromosomes were incubated, followed by addition of APC/C and assay for its activity. (B) Immunoprecipitated APC/C was first incubated with Cdc20 to form an active complex (''Pre-activated APC/C''). APC/C was affinity recovered and subsequently incubated with chromosomes and increasing amounts of BubR1, Bub3, and Mad2, and APC/C activity was assayed.
(C) Quantitation of (red triangles) coincubated and (blue squares) preactivated Cdc20-stimulated APC/C activity. Error bars represent standard error of the mean calculated from at least three independent assays.
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On the other hand, incubation with chromosomes produced a proportion of BubR1 and Cdc20 that eluted earlier (e.g., fraction 11), consistent with production of a larger complex or one with a more extended structure so as to produce a higher Stoke's radius. This complex was comprised of approximately equal molar amounts of BubR1 and Cdc20, but only trace levels of Mad2. (A) Chromosomes were incubated with BubR1, Bub3, Mad2, and Cdc20 (1:1:1:5); the chromosomes were subsequently removed by centrifugation, and (blue) the supernatant fraction was assayed for activation of APC/C for cyclin B ubiquitination. A parallel assay was done (red) without chromosome removal or (white) without initial chromosome addition. (B) Chromosomes were initially incubated with Mad2 and Cdc20 (1:5); the chromosomes were subsequently removed, and BubR1/Bub3 added to the supernatant fraction after chromosome removal (green). The resulting ubiquitination activity was compared to (blue) inhibition produced by incubating chromosomes with Mad2, BubR1, and Bub3 prior to chromosome removal or (white) no chromosomes added. (C) Cdc20 was incubated with a 5-fold excess Mad2 and chromosomes. At the indicated time points, (blue squares) a fraction of the incubation was removed and assayed for APC/C activity. Chromosome-mediated catalysis was compared to (red triangles) chromosome-independent inhibitor production over time.
DISCUSSION
Error bars represent standard error of the mean calculated from at least three independent assays.
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Catalytic Kinetochores Generate a Cdc20 Inhibitor catalyze production of an initial Mad2-Cdc20 inhibitor, significantly accelerating the initial rate of its production. Unattached kinetochores did not affect inhibition by Bub3/BubR1 in the absence of Mad2. Production of at least two inhibitors can be enhanced by unattached kinetochores: one containing diffusible Cdc20 and another in which Cdc20 is already bound in a megadalton complex to APC/C, consistent with reports that Cdc20 and checkpoint proteins are present in two complexes with differing sizes during mitosis (Braunstein et al., 2007; Morrow et al., 2005; Sudakin et al., 2001; Wang et al., 2006) . Both inhibitors prevent recognition by APC/C of cyclin B as an ubiquitination substrate. Disruption of cyclin B ubiquitination by a kinetochore-derived inhibitor even while Cdc20 remains bound to APC/C provides a potential explanation for the differential timing of destruction of cyclins A and B. Instead of simple sequestration of Cdc20, a kinetochore-derived mitotic checkpoint inhibitor bound to APC/C Cdc20 may block recognition of cyclin B as an ubiquitination substrate, while permitting APC/C Cdc20 -mediated ubiquitination and destruction of cyclin A, an event that is known to initiate immediately after mitotic entry (den Elzen and Pines, 2001; Geley et al., 2001) . Despite amplification of Cdc20 inhibition when equal molar levels of BubR1, Mad2, and Cdc20 were added, we found no evidence for assembly of a quaternary MCC-like complex as a bona fide inhibitor produced by unattached kinetochores. Rather, almost all Cdc20 shifted to a complex comigrating with 
Cdc20 BubR1 Bub3 Mad2 7 8 9 10 11 12 6 7 8 9 10 11 12 6 7 8 9 1 0 1 1 1 2 2 1 1 1 0 1 9 8 7 6 2 1 1 1 0 1 9 8 7 6 6 Figure 6 . Unattached Kinetochores Facilitate BubR1, Bub3, and Mad2 Association with APC/C Cdc20 (A) APC/C was incubated with preincubated combinations of Cdc20, Mad2, BubR1, Bub3, and chromosomes, recovered, peptide-eluted from Affiprep beads, and analyzed for bound components by immunoblotting. (B-E) APC/C was incubated with Cdc20 and increasing amounts of BubR1, Bub3, and Mad2 wt (or Mad2 RQ ) either in the (blue squares) presence or (red triangles) absence of chromosomes, and treated as in (A). The amounts of eluted (B) BubR1, (C) Bub3, and (D) Mad2 wt (or Mad2 RQ ) were measured against a dilution series of purified protein and quantified relative to the amount of Cdc20 bound to APC/C. Values were plotted as fold change over the initial (13) nonchromosome incubated eluted amounts. (E) The relative stoichiometry of BubR1 molecules to Mad2 molecules associated with the APC/C complex. BubR1 relative stoichiometry to Mad2 increased above 1:1 when chromosomes were present, but remained approximately 1:1 or below when Mad2 wt was replaced with Mad2 RQ regardless of the presence of chromosomes. (F) APC/C incubated with combinations of Cdc20, Mad2, BubR1, Bub3, and chromosomes was recovered, eluted from Affiprep beads, fractionated over a sucrose gradient, and analyzed by immunoblotting for bound components.
Catalytic Kinetochores Generate a Cdc20 Inhibitor the majority of BubR1 but containing very little Mad2 ( Figure 7E ). Also arguing against a contribution in kinetochore-derived checkpoint signaling, we note that MCC-like complexes in animal cells are present outside of mitosis (Sudakin et al., 2001) , and their formation in yeast continues in the absence of a functional centromere/kinetochore (Fraschini et al., 2001) . All of this supports an MCC-like, premade Cdc20 inhibitor produced in a kinetochore-independent manner in interphase that restrains APC/C ubiquitination activity for cyclin B just after mitotic entry, which has been referred to as a ''timer'' (Meraldi et al., 2004) .
More importantly, at physiologically relevant concentrations of unattached kinetochores and Mad2, chromosomes catalyzed production of Cdc20 inhibition of cyclin B recognition by APC/C by at least 8-fold relative to inhibitors formed spontaneously in the absence of chromosomes. The actual in vivo effect is likely to be much greater than what we have observed in vitro, since chromosome purification resulted in partial loss of signaling molecules from kinetochores, including a proportion of Mad1 and kinases that include Bub1, BubR1, and Aurora B.
Sequentially Produced Mitotic Checkpoint Inhibitors
Initiated by a Mad1/Mad2 Template at Kinetochores Chromosome amplification of Cdc20 inhibition required Mad1 recruitment of Mad2 to kinetochores and dimerization-competent Mad2 (Figures 3E and 3F) , thereby providing a direct demonstra-tion that a Mad1:Mad2 core complex recruits and converts soluble ''inactive'' Mad2 into a more potent inhibitor of Cdc20. At least part of this is from action of kinetochores on Mad2. Although it has previously been argued that the kinetochore may sensitize the APC/C for checkpoint-mediated inhibition (Acquaviva et al., 2004; Sudakin et al., 2001) , direct contact of chromosomes with APC/C was not required to amplify inhibition ( Figures 5A and 5B ). While we by no means exclude a kinetochore-dependent function of BubR1 from roles in microtubule attachment and chromosome alignment (Ditchfield et al., 2003; Elowe et al., 2007; Lampson and Kapoor, 2005) or from further amplification of a kinetochore derived signal (Mao et al., 2003) , kinetochore-mediated enhancement of Cdc20 inhibition did not require BubR1 localization to or contact with kinetochores. We conclude that immobilized, kinetochore-bound Mad1/Mad2, but not BubR1, catalyzes conversion at the kinetochore of soluble, open Mad2 into a form with its seatbelt domain poised for Cdc20 capture. Further support for this conclusion includes evidence that kinetochore-bound BubR1 is nonessential, as reported by the accompanying report from Van Deursen and colleagues (Malureanu et al., 2009 [this issue of Developmental Cell] ).
Moreover, incubation of physiologically relevant concentrations of each component ultimately produced most Cdc20 bound to BubR1, not Mad2, whether or not chromosomes were present (Figures 7D and 7E) . In fact, amplification of Cdc20 inhibition by Fractions eluted from the column were analyzed for BubR1, Bub3, Cdc20, and Mad2 content by immunoblotting for those components. (F) A model for generation of a ''wait anaphase'' mitotic checkpoint inhibitor by sequential production of Mad2-Cdc20 and BubR1-Cdc20 inhibitors. Cytosolic Mad2 in an initially open conformation is recruited to unattached kinetochores via an immobilized Mad1:Mad2 heterodimer. This second molecule of Mad2 binds in an activated conformation that is poised for capture of Cdc20 either while kinetochore bound or after release. This transient Mad2-Cdc20 complex promotes handoff of Cdc20 to BubR1, thereby inhibiting the ability of that Cdc20 to activate ubiquitination by APC/C of cyclin B, both by sequestering Cdc20 from APC/C and by inhibiting Cdc20 while APC/C bound.
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Catalytic Kinetochores Generate a Cdc20 Inhibitor unattached kinetochores was accompanied by a shift to a more rapidly eluting Bub3/BubR1-Cdc20 complex, without a stable pool of Mad2-Cdc20. Evidence from Pines and colleagues also demonstrated that most Cdc20 is complexed with BubR1 in vivo, rather than Mad2 (Nilsson et al., 2008) . We propose a model from all of this ( Figure 7F ) in which Mad1/Mad2 immobilized at kinetochores templates conversion of an inactive, open Mad2 to one capable of transient capture of Cdc20 followed by relay to BubR1 as sequentially produced mitotic checkpoint inhibitors that may be soluble or APC/C bound. This evidence supports Mad2-Cdc20, and perhaps an MCC-like complex, as a transient intermediate in kinetochore-mediated checkpoint signaling and one that is a precursor to BubR1-Cdc20. Further, Bub3/BubR1 binds to APC/C, but only in a Mad2-dependent manner that is stimulated by unattached kinetochores (Figure 6A ), demonstrating that kinetochores facilitate loading of Bub3/BubR1 onto APC/C. That BubR1-APC/C Cdc20 is produced indirectly by unattached kinetochores as the final Cdc20 inhibitor would also support suggestions that BubR1 acts as a nonproductive pseudosubstrate of the APC/C (Burton and Solomon, 2007) or mediates Cdc20 proteolytic turnover (King et al., 2007; Nilsson et al., 2008; Pan and Chen, 2004) .
Combining kinetochore-derived Bub3/BubR1-Cdc20 with evidence for two Cdc20 binding sites on BubR1 (Davenport et al., 2006) further suggests that the spontaneous and kinetochore-derived Bub3/BubR1-Cdc20 complexes may represent generation of Cdc20 bound at the two different sites, respectively, a point now testable with the appropriate BubR1 mutants.
EXPERIMENTAL PROCEDURES
Protein Purification
Recombinant proteins His-E1, His-UbcH10, His-Mad2 wt , His-Mad2 RQ , His-Mad2 DC , His-Mad2 RQ-DC , and His-Myc-Cyclin B 1-102 were purified from bacteria after induction, while His-Cdc20, His-Cdh1, His-Bub3, and GST-BubR1 were purified from SF9/Hi5 insect cells after baculovirus infection using HIS tag purification as previously described . GST-BubR1 purified over glutathione sepharose beads was eluted by PreScission protease digestion to cleave the GST tag and was separated from oligomeric species by gel filtration. APC/C was immunoprecipitated from Xenopus egg extracts cycled into interphase with calcium addition, or from checkpoint-active mitotic extracts after sperm and nocodazole addition.
Chromosome Purification
HeLa cells stably expressing YFP-H2B were treated with 50 ng/ml colcemid for 16 hr. Mitotic cells were collected by shake-off and subjected to hypotonic conditions in modified PME buffer (MPME; 5 mM PIPES [pH 7.2], 10 mM NaCl, 5 mM MgCl 2 , 0.5 mM EGTA, and 2 mM EDTA). The swollen cells were resuspended in 10 volumes of MPME buffer supplemented with 10 mg/ml LPC, 0.5 mM spermine, 1 mM spermidine, 10 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, and 0.1% digitonin. The cells were disrupted using a dounce homogenizer to produce an initial lysate (total lysate). The lysate was centrifuged at 900 3 g for 1 min to pellet intact nuclei and cell debris (cleared lysate). The NaCl concentration of the solution was elevated to 100 mM (hsMPME), and the lysate was placed over a sucrose step gradient (30%-40%-50%-60%) prepared with supplemented hsMPME and centrifuged for 15 min at 5000 3 g. The flocculent white material at the 40%-50% and 50%-60% interface containing chromosomes was harvested (first sucrose gradient). The chromosomes were washed in 8 volumes of supplemented hsMPME buffer, sedimented for 15 min at 2900 3 g, suspended in supplemented hsMPME, placed over a second sucrose gradient, and reharvested as described above. The chromosomes were washed a second time and resuspended in 10 volumes of chromosome storage buffer (hsMPME containing 50% sucrose, 0.5 mM spermine, 10 mM NaF, 1 mM Na 3 VO 4 , 10 mg/ml LPC), aliquoted, frozen in liquid nitrogen, and stored at À80 C.
APC/C Ubiquitination/Depletion Assays APC/C ubiquitination assays were performed as previously described , utilizing different anti-Cdc27 antibodies depending on whether ubiquitination (Fang et al., 1998a) or depletion of cyclin B was measured (Tugendreich et al., 1995) . To analyze the depletion assays, film exposures within a nearly linear range based on an internal loading gradient of inactive APC/C were selected. The intensity of bands corresponding to unubiquitinated cyclin B on immunoblots was quantified using NIH Image J software. The intensities of each lane were normalized against inactive APC/C (no Cdc20 added: 0%) and fully active APC/C (with Cdc20, no inhibitors added: 100%). Each depletion assay was repeated at least in triplicate and the average represented in graph format, with bars representing standard error of the mean.
Immunofluorescence of Chromosomes
Purified chromosomes were fixed in formaldehyde, placed over a 33% glycerol cushion, and sedimented onto coverslips by centrifugation for 20 min at 5500 3 g. The chromosomes were subsequently fixed in ice-cold methanol and processed as described (Weaver et al., 2003) . The coverslips were stained with the following antibodies: Hpx anti-CENP-E (Brown et al., 1996) , sheep SB1 anti-Bub1 (Taylor et al., 2001) , BB3-8 anti-Mad1 (De Antoni et al., 2005) , rabbit anti-Mad2 (Kops et al., 2004) , and ACA sera for identifying centromeres (Antibodies Inc.) Chromosomes were imaged using a DeltaVision deconvolution microscope (Applied Precision). Optical sections were taken at 0.15 intervals and deconvolved using SoftWoRx software (Applied Precision). The images were generated by projecting the sum of the stack of deconvolved images. Images were processed after equivalent scaling.
Labeling of Mad2 and Its Localization onto Kinetochores
Mad2 and mutants of it were fluorescently labeled using FluoReporter Rhodamine Red-X Protein Labeling Kit by Molecular Probes. Equivalently labeled batches of Mad2 were selected. Chromosomes were incubated with 480 nM rhodamine-labeled Mad2 fractions for 1 hr at room temperature. For Mad1 antibody blocking, the chromosomes were first incubated with the Mad1 antibody for 10 min and subsequently with the labeled Mad2. The chromosomes were treated for imaging as described above. Kinetochore fluorescence was quantified using the average intensity of traced kinetochore shape, as determined by ACA staining, using MetaMorph Imaging software (Molecular Devices).
APC/C Complex Affinity, Elution, and Sucrose Sedimentation APC/C was immunoprecipitated using a peptide-derived Cdc27 antibody (Herzog and Peters, 2005) conjugated to Affiprep Protein A (BioRad) beads for 2 hr from Xenopus interphase extracts. The washed APC/C beads were incubated with recombinant checkpoint proteins for 1 hr at room temperature. The beads were washed twice with 20 volumes of TBS buffer to remove unbound proteins. The APC/C complex was eluted from the beads by Cdc27 peptide competition as described (Herzog and Peters, 2005) and analyzed by immunoblotting. Sucrose sedimentation of APC/C complexes was performed by scaling up APC/C elution 5-fold and placing the eluate over a 5%-35% sucrose gradient. The gradients were centrifuged for 4 hr at 50,000 rpm in a Beckman tabletop ultracentrifuge with TLS55 swinging bucket rotor. The fractions were collected from the top, and proteins in each fraction were precipitated with trichloroacetic acid (TCA) before used in immunoblotting.
Gel Filtration of Complexes of Mad2, BubR1, Bub3 and Cdc20 Equimolar combinations of BubR1, Bub3, Cdc20, and Mad2 proteins were incubated with or without purified mitotic chromosomes for 30 min at room temperature, and protein complexes generated were resolved by Superose 6 gel filtration. Proteins in each column fraction were concentrated by TCA precipitation and analyzed by immunoblotting.
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